肺移植后的肺栓塞与慢性肺合移植功能障碍的发展的关联
Justin C Magin1, Chun Xu2, Sarah Peskoe2
1Duke University Medical Center, Durham, NC.
Transplantation direct
|January 24, 2024
概括
肺移植后的肺栓塞 (PE) 与更糟糕的生存率和慢性肺异位移植功能障碍 (CLAD) 的更高风险有关. 肺栓塞严重性指数 (PESI) 评分不能可靠地预测肺移植接受者的这些结果.
科学领域:
- 肺部病理学 肺部病理学
- 移植手术 移植手术
- 心血管医学 心血管医学
背景情况:
- 肺栓塞 (PE) 是肺移植后的一种罕见但严重的并发症.
- 在PE时间/严重程度和慢性异位移植肺功能障碍 (CLAD) 之间的关系是不确定的.
研究的目的:
- 调查肺栓塞 (PE) 与肺移植接受者 (LTRs) 的结果之间的关联.
- 评估PE时间和严重程度对移植缺陷和CLAD发展的影响.
主要方法:
- 肺移植接受者 (LTRs) 的回顾性队列分析.
- 通过CT血管学或V/Q扫描确认PE诊断.
- 使用肺栓塞严重性指数 (PESI) 评分评估PE严重程度.
- 对整体存活率,移植失败和CLAD的分析.
主要成果:
- PE发生在6.14%的LTR中,随访时间中位数为1623天.
- 长期发育与增加的死亡率 (HR 1.8) 和移植失败 (HR 1.8) 有显著的关联.
- 乳腺发育也增加了患有CLAD的风险 (HR 1.7);仅仅心脏病发作并没有影响结果.
- PESI得分类别不是死亡或CLAD的重要预测因素.
结论:
- 肺移植受体 (LTRs) 的肺栓塞 (PE) 与生存率降低和慢性肺全移植功能障碍 (CLAD) 的风险增加有关.
- 肺栓塞严重性指数 (PESI) 评分不是这种患者群体中死亡率或CLAD的可靠预测指标.
更多相关视频
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.8K
06:15Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
882
相关概念视频
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
